← All companies

GOVX

GeoVax Labs, Inc.

GOVX Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.72

-0.00 -0.68%

Key statistics

from XBRL data in SEC filings

Market cap

$5.31M

Revenue (TTM)

$0.00

Net income (TTM)

-$20.4M

EPS (TTM)

$-6.05

P/E ratio

—

Dividend yield

—

Free cash flow

-$21.5M

Cash

$3.14M

Total assets

$4.64M

Gross margin

—

52-week range

$0.64 – $20.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 27, 2026 8-K Results of operations (earnings release) Jul 27, 2026 8-K Delisting notice or listing-rule failure Jul 10, 2026 8-K Shareholder vote results Jun 17, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 19, 2026 8-K Results of operations (earnings release) May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Entered a material agreement; Unregistered sale of equity May 7, 2026 8-K Results of operations (earnings release) Apr 15, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Entered a material agreement; Unregistered sale of equity Mar 31, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 17, 2026 8-K Modified rights of security holders; Amended charter or bylaws Jan 12, 2026 8-K Entered a material agreement; Regulation FD disclosure Dec 22, 2025 8-K Shareholder vote results Nov 26, 2025 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Sep 30, 2025 8-K Delisting notice or listing-rule failure Aug 1, 2025 8-K Results of operations (earnings release) Jul 29, 2025 10-Q Quarter ended 2025-06-30 Jul 28, 2025 8-K Entered a material agreement; Regulation FD disclosure Jul 2, 2025 8-K Shareholder vote results Jun 5, 2025 8-K Results of operations (earnings release) May 1, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Terminated a material agreement Apr 14, 2025 8-K Results of operations (earnings release) Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Entered a material agreement; Regulation FD disclosure Mar 25, 2025 8-K Shareholder vote results Jan 22, 2025 8-K Other events Dec 18, 2024 8-K Delisting notice or listing-rule failure Nov 18, 2024 8-K Results of operations (earnings release); Other events Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Other events Oct 16, 2024 8-K Other events Oct 15, 2024 8-K Other events Oct 1, 2024 8-K Entered a material agreement Sep 25, 2024 8-K Other events Sep 17, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 30, 2024